Altimmune (ALT) EBIT (2010 - 2026)
Altimmune (ALT) reported EBIT of -$26.23 million for Q2 2026, compared with -$22.92 million a year earlier.
Powered by 
Analysis
Altimmune (ALT) EBIT (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Altimmune's EBIT came in at -$100.23 million; for FY2025, it was -$94.49 million.
- By year, EBIT came in at -$103.17 million in FY2024, -$95.93 million in FY2023, -$87.74 million in FY2022 and -$96.91 million in FY2021.
- Five-year quarterly EBIT spans a low of -$33.62 million in Q4 2023 and a high of -$18.01 million in Q2 2023.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$24.24 million (Q1 2026), -$28.89 million (Q4 2025) and -$20.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Altimmune | 575.64 Mn | 575.64 Mn | - | -26.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.23 Mn |
| Mar 31, 2026 | -24.24 Mn |
| Dec 31, 2025 | -28.89 Mn |
| Sep 30, 2025 | -20.86 Mn |
| Jun 30, 2025 | -22.92 Mn |
| Mar 31, 2025 | -21.82 Mn |
| Dec 31, 2024 | -24.87 Mn |
| Sep 30, 2024 | -24.77 Mn |
| Jun 30, 2024 | -26.75 Mn |
| Mar 31, 2024 | -26.79 Mn |
| Dec 31, 2023 | -33.62 Mn |
| Sep 30, 2023 | -22.54 Mn |
| Jun 30, 2023 | -18.01 Mn |
| Mar 31, 2023 | -21.76 Mn |
| Dec 31, 2022 | -23.09 Mn |
| Sep 30, 2022 | -24.75 Mn |
| Jun 30, 2022 | -20.40 Mn |
| Mar 31, 2022 | -19.50 Mn |
| Dec 31, 2021 | -23.99 Mn |
| Sep 30, 2021 | -33.20 Mn |
API Access
Altimmune EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();